✦ LIBER ✦

Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation—A Similar Experience

✍ Scribed by Eric C. Santos; Jolynn Sessions; Don Hutcherson; Christopher Flowers; Amelia Langston; Edmund K. Waller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term Outcome of Hodgkin Disease Pat

✍ Navin Wadehra; Sherif Farag; Brian Bolwell; Patrick Elder; Sam Penza; Matt Kalay 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Busulfan and Cyclophosphamide has Simila

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Dean; B. Pohlman; R. Sobecks; S. Andrese 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Pharmacokinetic-Directed High-Dose Busul

✍ Zhang, Hongzheng; Graiser, Michael; Hutcherson, Donald A.; Dada, M. Olufemi; McM 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Improved Outcomes in Intermediate- and H

✍ Charu Aggarwal; Sameer Gupta; William P. Vaughan; Gene B. Saylors; Donna E. Salz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Long-term outcome of high-dose melphalan

✍ Perz, J B; Rahemtulla, A; Giles, C; Szydlo, R M; Davis, J; Gopaul, D; Gillmore, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

High-dose busulfan, cyclophosphamide, an

✍ Farag, S S; Bolwell, B J; Elder, P J; Kalaycio, M; Lin, T; Pohlman, B; Penza, S; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB